CRANBURY, N.J.--(BUSINESS WIRE)--Dec 10, 2024-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, announced today that it intends to offer and sell $150 million of shares of its common stock in an underwritten public offering. In addition, Rocket intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of shares of its common stock offered in the public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Morgan Stanley, Leerink Partners and Cantor are acting as joint book-running managers for the offering, and LifeSci Capital is acting as lead manager for the offering. The shares are being offered by Rocket pursuant to an effective shelf registration statement that was previously filed with the U.S. Securities and Exchange Commission (the “SEC”). The offering is being made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement and the accompanying prospectus relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC’s website at http://www.sec.gov . When available, copies of the prospectus supplement relating to the offering may be obtained from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, by email at prospectus@morganstanley.com ; Leerink Partners LLC, Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, or by telephone at (800) 808-7525 ext. 6105 or by email at syndicate@leerink.com ; or Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th Floor, New York, New York, 10022, or by email at prospectus@cantor.com . You may also obtain a copy of this document free of charge by visiting the SEC’s website at http://www.sec.gov . This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. About Rocket Pharmaceuticals, Inc. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders. Rocket’s innovative multi-platform approach allows us to design the optimal gene therapy for each indication, creating potentially transformative options that enable people living with devastating rare diseases to experience long and full lives. Rocket’s lentiviral (LV) vector-based hematology portfolio consists of late-stage programs for Fanconi Anemia (FA), a difficult-to-treat genetic disease that leads to bone marrow failure (BMF) and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe pediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, and Pyruvate Kinase Deficiency (PKD), a monogenic red blood cell disorder resulting in increased red cell destruction and mild to life-threatening anemia. Rocket’s adeno-associated viral (AAV) vector-based cardiovascular portfolio includes a late-stage program for Danon disease, a devastating heart failure condition resulting in thickening of the heart, an early-stage program in clinical trials for PKP2-arrhythmogenic cardiomyopathy (ACM), a life-threatening heart failure disease causing ventricular arrhythmias and sudden cardiac death, and a pre-clinical program targeting BAG3-associated dilated cardiomyopathy (DCM), a heart failure condition that causes enlarged ventricles. Rocket Cautionary Statement Regarding Forward-Looking Statements Various statements in this release concerning the timing and completion of the public offering on the anticipated terms or at all may constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995, as amended, and other federal securities laws. All such forward-looking statements are based on management’s current expectations of future events and are subject to a number of substantial risks and uncertainties, many of which are outside Rocket’s control, that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include fluctuations in Rocket’s stock price, changes in market conditions and satisfaction of customary closing conditions related to the public offering, as well as those risks more fully discussed in the section entitled "Risk Factors" in the prospectus supplement and registration statement referenced above, Rocket’s Annual Report on Form 10-K for the year ended December 31, 2023, filed February 27, 2024 with the SEC and subsequent filings with the SEC including our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. There can be no assurance that Rocket will be able to complete the public offering on the anticipated terms. Accordingly, you should not place undue reliance on these forward-looking statements. All such statements speak only as of the date made, and Rocket undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law. View source version on businesswire.com : https://www.businesswire.com/news/home/20241210060247/en/ CONTACT: Media & Investors Meg Dodge mdodge@rocketpharma.comMedia Kevin Giordano media@rocketpharma.comInvestors Brooks Rahmer investors@rocketpharma.com KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: ONCOLOGY HEALTH GENETICS OTHER HEALTH GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY SOURCE: Rocket Pharmaceuticals, Inc. Copyright Business Wire 2024. PUB: 12/10/2024 04:01 PM/DISC: 12/10/2024 04:00 PM http://www.businesswire.com/news/home/20241210060247/enTitle: Israeli Military Destroys All Syrian Air Defense Bases in Ongoing Massive Airstrikes
In conclusion, Isco's list of toughest opponents in his career provides a glimpse into the high level of competition and talent present in modern football. The inclusion of three Barcelona players reflects the intense rivalry between Real Madrid and Barcelona, while the presence of Chiellini and Kimmich highlights the global nature of footballing competition. Isco's experiences facing these elite opponents showcase his adaptability and skill as a midfielder while emphasizing the challenges and rewards of competing at the highest level of the sport.In response to the growing public outrage and pressure from opposition parties, the South Korean parliament has passed a resolution calling for the immediate arrest of Cho Kuk. The swift action taken by lawmakers reflects the seriousness of the situation and the need for accountability in the face of corruption.
However, the increasing popularity of these bathhouses has also led to some challenges, such as the overcrowding of the luggage room. With more and more guests flocking to experience the luxury and relaxation of these bathhouses, the staff are struggling to keep up with the demand and ensure that all belongings are safely stored. Despite these challenges, the allure of the lavish bathhouses remains strong, drawing in visitors from far and wide.From Harley Street to Ilkley... Dr Ellie opens new skin clinic in the town
In conclusion, while the top 30 positions in the ITTF world rankings for both men and women remained unchanged, the rise of Doo Hoi Kem to world number 35 is a significant achievement. Her hard work, talent, and dedication have propelled her to new heights in the world of table tennis, and she is poised to continue making her mark on the international stage. Doo Hoi Kem's success serves as an inspiration to aspiring players around the world and a reminder that with passion and perseverance, dreams can become a reality.Holiday shopping can be, well...hard. No one seems to make wish lists anymore, and every time you try to ask a loved one what they would want, you are met with responses like “ I don’t need anything this year ” or “ Don’t spend your money on me. ” It seems like an impossible feat. Todd Snyder , a brand that is known for creating high-quality menswear, is here to help. From wool sweaters to watches, they put together a luxury gift guide filled with their best-selling products so you can easily find a present for the hardest person on your list (we’re looking at you, Dads, brothers, and Fathers-in-Law of the world). Shop 20 of our top selections below. $198.00 Donegal wool dates all the way back to 18th-century Ireland and is known for its naturally insulating and breathable properties. This crewneck sweater is made of that same spotted, multi-colored yarn and is available in four different chic colors. Grab one for everyone on your list before it sells out — because it will. $228.00 Selvedge jeans shot to mainstream popularity in the last decade or so, but let’s be real —thanks to the likes of Bob Marley, Elvis Presley, and Bob Dylan , they’ve also been cool. This pair has a roomy but not baggy fit, comes with multiple coin pockets, and is available in sizes 28 to 38. $561.00 Sleek, durable, and currently on sale for under $600, this Unimatic Classic Series Watch looks like a luxury timepiece, but it won’t break the bank. It’s water-resistant, made with stainless steel, and comes in a 40 mm size — proving that the best things really do come in the smallest packages. $98.00 Todd Snyder and Champion first collaborated in 2023, and their “Relaxed Drop” is still one of our favorites to date. Take this vintage-inspired sweatshirt, for instance: It’s lightweight, can be paired with jeans or joggers, and has a cool, sun-faded look that doesn’t try too hard. $155.00 If you’re having a hard time shopping for your Dad, Father-in-Law, or estranged co-worker whose name you pulled for office Secret Santa, may I present to you this Leather Hunting Flask . With the ability to fit 200 ml of liquid it comes with two stainless steel cups and a hand-crafted Koozie — you can’t go wrong. $248.00 While this Donegal Polo is a far cry from the Donegal Sweaters worn by Irish fisherman, we won’t judge if you want to still want to sing a Sea Shanty while wearing it. Soft and stylish, it’ll become your new closet staple. $118.00 Beanies aren’t always the easiest type of headwear to rock. For lack of better words, sometimes they can look just plain...wrong. Luckily, Todd Snyder seemed to crack the code with this Brushed Alpaca Beanie . Soft, stretchy, and available in three stylish colors, it’ll keep you warm without looking like Eric Cartman from South Park. $99.00 $188.00 47% off Gifting someone a flannel for the holidays is a tradition as old as time, but this Todd Snyder option takes it up a modern notch. Made with 100% cotton, it’s comfortable, breathable, and works for just about anybody and any body. $70.00 With notes of Sea Lavender, Citrus, and Suede, this 7 oz candle makes a great stocking stuffer or white elephant present. But a word of warning: it smells so good you’ll want to keep it for yourself. $247.00 Make him feel like he’s living in the lap of luxury with these cashmere-lined gloves . Crafted in Britain by John Dent — a brand that has made accessories for Movie Stars and Monarchs alike — they’re hand-sewn, versatile, and come in multiple size options. $710.00 Of course, if you’re going to get him cashmere-lined gloves, you might as well get him these Suede Indy Boots , too. Made famous by Harrison Ford in Indiana Jones , they’re an elegant option that can be worn on any adventure. $2,050.00 A briefcase makes a great holiday gift because it’s something that they’ll actually use all year round. This leather option features a removable strap, laptop sleeve, and chic brass hardware, showing that you can still be stylish while keeping all of your shit safe. $498.00 This is the type of sweater that you’ll never want to take off — end of story. Made with a soft-to-the-touch yarn and cool 3D texture, you’ll find that the best time to wear a plaid sweater is quite literally all the time. $188.00 Todd Snyder’s Chinos are one of the brand’s best-selling styles, and for good reason. They boast an easy-to-wear fit that is super-flattering, super-comfortable, and, you guessed it, super-versatile. Snag them in all eight colors, and you’ll never struggle to find bottoms again. $307.00 People often shy away from sunglasses as a present because they’re a rather personal preference—but you don’t have to worry about that with this beige pair. Simple and clean, they’ll look stunning on any face shape. $998.00 The perfect hybrid between a coat and button-down, this overshirt is roomy, made with a soft knit-cashmere blend, and will help elevate any ensemble. $98.00 Socks can often be seen as a “cop-out” gift, but I think (and will die on this hill) that they make a great present. And these aren’t just any socks ; they’re made with cashmere, so they double as house slippers, workwear, and everything in between. $145.00 Take it from someone who wants jewelry for every holiday and birthday (okay, and minor inconvenience): You can never go wrong with a piece of precious metals. Made from sterling silver (but also available in gold), this chain bracelet is as surprising as it is subtle. $998.00 This is THE cardigan (and no, we’re not talking about the rock band that sings “Lovefool”). It’s heavy but doesn’t weigh you down, has a cool intricate pattern, and has a hand-stamped zipper for added detail. It’s everything you could want from a sweater and more. $60.00 Whether they display it on their coffee table or read it cover to back, this book about infamous product designer Dieter Rams is a one-of-a-kind gift that sparks intrigue and interest.
As the release date draws near, anticipation for "The Lord of the Rings: Battle of Rohan" continues to build, with fans eagerly counting down the days until they can experience the film for themselves. With its blend of action, adventure, and heart, the animated film promises to be a fitting tribute to Tolkien's enduring masterpiece and a must-see for fans of fantasy storytelling.
Following closely behind Messi is another Barcelona stalwart, Sergio Busquets. The defensive midfielder is known for his intelligent positioning, exceptional passing range, and ability to break up opposition attacks. Isco's struggles against Busquets reflect the Spaniard's tactical acumen and influence in controlling the midfield battle. Busquets' presence on the pitch has often disrupted Real Madrid's attacking rhythm and posed a significant challenge for Isco to overcome.One of the main criticisms of algorithm-driven profit maximization is the phenomenon of "systemic indifference." Algorithms are programmed to prioritize certain objectives, such as maximizing revenue or reducing costs, often at the expense of other considerations such as ethics, social responsibility, or human well-being. This results in a sense of coldness or detachment in the way businesses interact with customers, employees, and society at large.At the top of the list is Kudus with an average of 3.8 successful dribbles per game. The Ghanaian midfielder has been a sensation for his team, consistently beating opposition defenders with his quick feet and agility. His ability to take on players one-on-one and create opportunities for his team has made him a standout performer in the league this season.